(Q57829480)

Maurits W van Tulder

8

0 references

Lex M. Bouter

Lex M Bouter

6

0 references

Martine De Bruijne

4

Martine C de Bruijne

0 references

Wim A B Stalman

7

Wim A B Stalman

0 references

author name string

Oscar H Brook

2

0 references

Hein P J van Hout

3

0 references

Hugo Nieuwenhuyse

https://scigraph.springernature.com/pub.10.2165/00019053-200725010-00004

5

0 references

publication date

2007

0 references

published in

PharmacoEconomics

0 references

volume

25

0 references

issue

1

0 references

page(s)

25-37

0 references

exact match

0 references

cites work

Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200725010-00004

Handling uncertainty in economic evaluations of healthcare interventions

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200725010-00004

Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200725010-00004

Impact of coaching by community pharmacists on drug attitude of depressive primary care patients and acceptability to patients; a randomized controlled trial

21 January 2018

1 reference

12 December 2020

Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

1 reference

12 December 2020

Impact of a collaborative pharmacy practice model on the treatment of depression in primary care.

1 reference

12 December 2020

Antidepressant use in clinical practice: efficacy v. effectiveness

1 reference

12 December 2020

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

12 December 2020

Compliance with antidepressant medication in the treatment of major depressive disorder in primary care: a randomized comparison of fluoxetine and a tricyclic antidepressant

1 reference

12 December 2020

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness

1 reference

12 December 2020

The CE plane: a graphic representation of cost-effectiveness.

1 reference

12 December 2020

The friction cost method for measuring indirect costs of disease.

1 reference

12 December 2020

Cost-effectiveness of a collaborative care program for primary care patients with persistent depression

1 reference

12 December 2020

Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care.

1 reference

12 December 2020

Compliance with tricyclic antidepressants: the value of four different methods of assessment

1 reference

12 December 2020

Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial.

1 reference

12 December 2020

Evidence review: efficacy and effectiveness of antidepressant treatment in primary care

1 reference

12 December 2020

Patient adherence in the treatment of depression

1 reference

12 December 2020

The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions

1 reference

12 December 2020

Economic evaluation and clinical trials: size matters

1 reference

12 December 2020

A multifaceted intervention to improve treatment of depression in primary care

1 reference

12 December 2020

The role of the primary care physician in patients' adherence to antidepressant therapy.

1 reference

12 December 2020

Costs, effects and C/E-ratios alongside a clinical trial.

1 reference

12 December 2020

A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP).

1 reference

12 December 2020

Depression in the community: the first pan-European study DEPRES (Depression Research in European Society)

1 reference

12 December 2020

Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group.

1 reference

12 December 2020

The impact of a pharmacist intervention on 6-month outcomes in depressed primary care patients

1 reference

12 December 2020

Missing... presumed at random: cost-analysis of incomplete data

1 reference

12 December 2020

A Pharmacy-Based Coaching Program to Improve Adherence to Antidepressant Treatment Among Primary Care Patients

1 reference

12 December 2020

Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic.

1 reference

12 December 2020

Cost-effectiveness of systematic depression treatment for high utilizers of general medical care

1 reference

12 December 2020

Collaborative management to achieve treatment guidelines. Impact on depression in primary care

1 reference

12 December 2020

The analysis of incomplete cost data due to dropout

1 reference

12 December 2020

Standardisation of costs: the Dutch Manual for Costing in economic evaluations

1 reference

12 December 2020

Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension

1 reference

12 December 2020

Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial.

1 reference

12 December 2020

Social and economic burden of mood disorders

1 reference

12 December 2020